NCT06087094View on ClinicalTrials.gov

A Trial of HRS-7450 in Chinese Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Cerebral Stroke
Interventions
DRUG

HRS-7450 ；Placebo

HRS-7450 or Placebo

All Listed Sponsors
lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06087094 - A Trial of HRS-7450 in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter